US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
Report says China is accelerating the forced urbanization of rural Tibetans
TAIPEI, Taiwan (AP) — An extensive report by Human Rights Watch says China is accelerating the force2024-05-22EastEnders was nearly a 'geriatric caravan park in the Northeast' as x
Ofcom Chairman Lord Michael Grade revealed to Boom Radio on Sunday that EastEnders almost become a '2024-05-22- (Xinhua) 16:42, September 26, 2023This aerial photo taken on Sept. 20, 2023 shows a transport ship s2024-05-22
Landslides hit Indonesia's Sulawesi island, killing at least 18 people
TANA TORAJA, Indonesia (AP) — A search and rescue team found 18 people killed by landslides on Indon2024-05-22Trump visits Minnesota after son Barron's Florida high school graduation
ST. PAUL, Minn. (AP) — Former President Donald Trump used a day off from his hush money trial Friday2024-05-22China surpasses U.S. in publishing most influential academic papers: report
(Xinhua) 08:21, September 21, 2023An international research team led by Chinese astronomers revealed2024-05-22
atest comment